Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHODS FOR STIMULATING HEMATOPOIETIC PROGENITORS USING HEPATOCYTE GROWTH FACTOR AND LYMPHOKINES.

  • Read more about METHODS FOR STIMULATING HEMATOPOIETIC PROGENITORS USING HEPATOCYTE GROWTH FACTOR AND LYMPHOKINES.
US Patent 5,362,716
Filed on 1992-07-20

METHOD FOR THE FLUORESCENT DETECTION OF A DNA SEQUENCE IN REAL TIME

  • Read more about METHOD FOR THE FLUORESCENT DETECTION OF A DNA SEQUENCE IN REAL TIME
US Patent 6,197,499
Filed on 1992-07-27

PHORBOL ESTER PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR TREATING INFLAMMATION

  • Read more about PHORBOL ESTER PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR TREATING INFLAMMATION
US Patent 5,420,162
Filed on 1992-07-31

METHODS FOR DIAGNOSIS AND THERAPY OF MULTIPLE SCLEROSIS

  • Read more about METHODS FOR DIAGNOSIS AND THERAPY OF MULTIPLE SCLEROSIS
US Application 07/360,845
Filed on 1989-06-02

METHOD FOR ESTIMATING MRNA CONTENT BY FILTER HYBRIDIZATION TO A POLYTHYMIDYLATE PROBE

  • Read more about METHOD FOR ESTIMATING MRNA CONTENT BY FILTER HYBRIDIZATION TO A POLYTHYMIDYLATE PROBE
US Application 07/908,814
Filed on 1992-07-08

DEVELOPMENT OF A VECTOR TO TARGET GENE EXPRESSION TO THE EPIDERMIS OF TRANSGENIC ANIMALS

  • Read more about DEVELOPMENT OF A VECTOR TO TARGET GENE EXPRESSION TO THE EPIDERMIS OF TRANSGENIC ANIMALS
US Application 07/876,289
Filed on 1992-04-30

NOVEL B-LYMPHOMA CELL LINE AND ANTIGEN

  • Read more about NOVEL B-LYMPHOMA CELL LINE AND ANTIGEN
US Application 07/934,106
Filed on 1992-08-21

OXYGEN SUBSTITUTED DERIVATIVES OF NUCLEOPHILE-NITRIC OXIDE ADDUCTS AS NITRIC OXIDE DONOR PRODRUGS

  • Read more about OXYGEN SUBSTITUTED DERIVATIVES OF NUCLEOPHILE-NITRIC OXIDE ADDUCTS AS NITRIC OXIDE DONOR PRODRUGS
US Patent 5,366,997
Filed on 1992-09-23

POLYHYDROXYLATED NAPTHYL 2-CARBOXYLATE, AND QUINOLYL AND ISOQUINOLYL 3-CARBOXYLATE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS

  • Read more about POLYHYDROXYLATED NAPTHYL 2-CARBOXYLATE, AND QUINOLYL AND ISOQUINOLYL 3-CARBOXYLATE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS
US Application 07/925,762
Filed on 1992-08-07

TYPE ALPHA PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE

  • Read more about TYPE ALPHA PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE
US Application 07/915,884
Filed on 1992-07-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1610
  • Page 1611
  • Page 1612
  • Page 1613
  • Page 1614
  • Page 1615
  • Page 1616
  • Page 1617
  • Page 1618
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health